Probiotic extracts ameliorate nasal allergy by inducing interleukin ‐35‒producing dendritic cells in mice

ConclusionEBI can suppress AR via inducing B10 cells. Thus, after carrying out required preclinical experiments and tests, EBI has the translational potential to be used in the treatment of AR and other allergic diseases.

Source: International Forum of Allergy and Rhinology - October 16, 2019 Category: Allergy & Immunology Authors: Jin ‐Mei Xue, Fei Ma, Yun‐Fang An, Li‐Min Suo, Xiao‐Rui Geng, Yan‐Nan Song, Li‐Hua Mo, Xiang‐Qian Luo, Xiao‐Wen Zhang, Da‐Bo liu, Chang‐Qing Zhao, Ping‐Chang Yang Tags: ORIGINAL ARTICLE Source Type: research